|
XRCC6BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.920900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.378050E-02 |
| Normal-vs-Stage2 |
4.689400E-01 |
| Normal-vs-Stage3 |
2.357900E-03 |
| Normal-vs-Stage4 |
6.601000E-04 |
| Stage1-vs-Stage2 |
3.204000E-01 |
| Stage1-vs-Stage3 |
3.364800E-01 |
| Stage1-vs-Stage4 |
1.277580E-01 |
| Stage2-vs-Stage3 |
1.460590E-01 |
| Stage2-vs-Stage4 |
8.264400E-02 |
| Stage3-vs-Stage4 |
6.267600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.778000E-03 |
| Normal-vs-AfricanAmerican |
2.247000E-01 |
| Normal-vs-Asian |
2.083300E-03 |
| Caucasian-vs-AfricanAmerican |
4.597800E-01 |
| Caucasian-vs-Asian |
3.046600E-01 |
| AfricanAmerican-vs-Asian |
1.490770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.026200E-02 |
| Normal-vs-Female |
5.640600E-03 |
| Male-vs-Female |
6.539400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.212440E-02 |
| Normal-vs-Age(41-60Yrs) |
8.199400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.025900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.308760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.820400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.517000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.532600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.590000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.388800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.460000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.477800E-01 |
| Classical-VS-Follicular |
1.437040E-03 |
| Classical-VS-Other |
2.302400E-01 |
| Classical-VS-Normal |
5.775700E-04 |
| Tall-VS-Follicular |
6.630400E-04 |
| Tall-VS-Other |
1.574790E-01 |
| Tall-VS-Normal |
9.561200E-04 |
| Follicular-VS-Other |
4.184400E-01 |
| Follicular-VS-Normal |
9.941000E-01 |
| Other-VS-Normal |
5.733600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.374400E-02 |
| Normal-vs-N1 |
4.580400E-04 |
| N0-vs-N1 |
2.392300E-02 |
|
|
